These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 12169845)

  • 21. Cost comparison of online haemodiafiltration with high-flux haemodialysis.
    Oates T; Cross J; Davenport A
    J Nephrol; 2012; 25(2):192-7. PubMed ID: 22038334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transfusion and recombinant human erythropoietin requirements differ between dialysis modalities.
    House AA; Pham B; Pagé DE
    Nephrol Dial Transplant; 1998 Jul; 13(7):1763-9. PubMed ID: 9681725
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomized trial of darbepoetin alfa for treatment of renal anemia at a reduced dose frequency compared with rHuEPO in dialysis patients.
    Vanrenterghem Y; Bárány P; Mann JF; Kerr PG; Wilson J; Baker NF; Gray SJ;
    Kidney Int; 2002 Dec; 62(6):2167-75. PubMed ID: 12427142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Changes in anemia management and hemoglobin levels following revision of a bundling policy to incorporate recombinant human erythropoietin.
    Hasegawa T; Bragg-Gresham JL; Pisoni RL; Robinson BM; Fukuhara S; Akiba T; Saito A; Kurokawa K; Akizawa T
    Kidney Int; 2011 Feb; 79(3):340-6. PubMed ID: 20962740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Correction of anemia in chronic kidney failure with lyophilized recombinant human erythropoietin using a subcutaneous approach].
    Amar M; Cendoroglo Neto M; Canziani ME; Nadaletto MA; Ajzen H; Draibe SA
    Rev Assoc Med Bras (1992); 1994; 40(2):101-7. PubMed ID: 7820145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endotoxin-free dialysate improves response to erythropoietin in hemodialysis patients.
    Matsuhashi N; Yoshioka T
    Nephron; 2002; 92(3):601-4. PubMed ID: 12372943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term on-line hemodiafiltration reduces predialysis beta-2-microglobulin levels in chronic hemodialysis patients.
    Lin CL; Yang CW; Chiang CC; Chang CT; Huang CC
    Blood Purif; 2001; 19(3):301-7. PubMed ID: 11244190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship among catheter insertions, vascular access infections, and anemia management in hemodialysis patients.
    Roberts TL; Obrador GT; St Peter WL; Pereira BJ; Collins AJ
    Kidney Int; 2004 Dec; 66(6):2429-36. PubMed ID: 15569336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reduction in erythropoietin doses by the use of chronic intravenous iron supplementation in iron-replete hemodialysis patients.
    Chang CH; Chang CC; Chiang SS
    Clin Nephrol; 2002 Feb; 57(2):136-41. PubMed ID: 11863124
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protocolized anemia management with erythropoietin in hemodialysis patients: a randomized controlled trial.
    Brimble KS; Rabbat CG; McKenna P; Lambert K; Carlisle EJ
    J Am Soc Nephrol; 2003 Oct; 14(10):2654-61. PubMed ID: 14514745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dialysis patients with the metabolic syndrome need less recombinant human erythropoietin for similar hemoglobin levels.
    Uyar ME; Tutal E; Bal Z; Sezer S
    Transplant Proc; 2013; 45(10):3481-4. PubMed ID: 24314937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of thalassemia on the response to recombinant human erythropoietin in dialysis patients.
    Cheng IK; Lu HB; Wei DC; Cheng SW; Chan CY; Lee FC
    Am J Nephrol; 1993; 13(2):142-8. PubMed ID: 8342581
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epoetin omega for treatment of anemia in maintenance hemodialysis patients.
    Sikole A; Spasovski G; Zafirov D; Polenakovic M
    Clin Nephrol; 2002 Mar; 57(3):237-45. PubMed ID: 11924756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. On-line hemodiafiltration: technique and therapy.
    Ledebo I
    Adv Ren Replace Ther; 1999 Apr; 6(2):195-208. PubMed ID: 10230890
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Orally administrated Juzen-taiho-to/TJ-48 ameliorates erythropoietin (rHuEPO)-resistant anemia in patients on hemodialysis.
    Nakamoto H; Mimura T; Honda N
    Hemodial Int; 2008 Oct; 12 Suppl 2():S9-S14. PubMed ID: 18837771
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical and economic significance of iron replacement in anemia treated with recombinant human erythropoietin in patients on hemodialysis].
    Vanková S; Safárová R; Horácková M; Herink J; Rychlík I; Bahbouh R; Půtová I
    Cas Lek Cesk; 2001 Apr; 140(7):209-13. PubMed ID: 11374225
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Efficacy and safety of long-term erythropoietin therapy in chronic hemodialysis patients with renal anemia].
    Ohkubo M; Ishimitsu T; Kawaguchi T; Abe M; Yagi S
    Nihon Jinzo Gakkai Shi; 1993 Feb; 35(2):171-7. PubMed ID: 8315880
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Management of anemia in erythropoietin-resistant hemodialysis patients.
    Dar Santos AE; Shalansky KF; Jastrzebski JP
    Ann Pharmacother; 2003 Dec; 37(12):1768-73. PubMed ID: 14632604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improved response to erythropoietin in peritoneal dialysis patients as compared to hemodialysis patients: role of iron deficiency.
    Raja R; Bloom E; Johnson R; Goldstein M
    Adv Perit Dial; 1994; 10():135-8. PubMed ID: 7999811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of anemia in patients with chronic renal insufficiency undergoing hemodialysis with recombinant human erythropoietin: 12 months' experience].
    de Sousa FT; Prata MM; Barbas JV; dos Santos JP
    Acta Med Port; 1990; 3(6):347-52. PubMed ID: 2089856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.